DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
van Bömmel F, Berg T.
Risks and benefits of discontinuation of nucleos(t)ide analogue treatment: a treatment concept for patients with HBeAg-negative chronic hepatitis B.
Hepatol Commun 2021;
5 (10) 1632-1648
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.